Human
Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.
Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.
Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.
Trials & Treatments
All Trials & Treatments stories- Reporting
ALS Nexus 2026: Experimental therapy shows early promise in SOD1-ALS
- HumanMouse
JP1 improved movement and survival in ALS model mice by targeting oxidative stress and autophagy
- Reporting
Tiziana Life Sciences to present Phase 2a BANYAN trial data at ALS Nexus 2026
- ReviewHumanAnimal
Review outlines why ALS trials fail and how more personalised treatment could help
- Human
A Canterbury study found inconsistent riluzole prescribing and monitoring in ALS
A severe hypersensitivity reaction was reported during tofersen therapy in ALS
- HumanMouseUpdated
ALS Untangled does not recommend ivermectin for ALS
- RecruitingPhase 1/2Updated
Phase 1/2 trial of TRCN-1023 opens to recruitment
- Results postedPhase 1Updated
Results posted for phase 1 trial of Autologous T-regulatory lymphocytes
Research
All Research stories- Case reportHuman
A VCP variant was linked to an unusual pattern of tau buildup in the nervous system
- Human
Study finds racial and ethnic differences in ALS progression and survival among U.S. Veterans
- HumanMouse
A drug candidate that blocks BAX protected motor neurons in laboratory studies
Engineered nanopores detect proteins linked to ALS and other diseases
- Human
ATXN2-related disease may sometimes follow a recessive inheritance pattern
- Human
A German registry study found that 12% of people with ALS lived at least 10 years after symptoms began
- Human
Butyrate reduced ALS-linked protein clumps and improved movement in worms and cells
- HumanMouse
Engineered delivery system clears harmful Tau and TDP-43 in disease models
- ReviewHumanAnimal
A review outlines how immune responses might guide more precise ALS treatments
- Systematic reviewHuman
Gold Coast criteria may help diagnose ALS earlier, but mimic conditions still need to be ruled out
Care & Living
All Care & Living stories- Observational studyHuman
Feeding-tube placement was feasible and safe in people with advanced ALS
- Discussion
Bulbar-onset ALS and low oxygen saturation (84%) on NIV.should I be worried
- Reporting
ALS Nexus 2026: Implantable device decodes patients’ brain signals
- Human
Virtual care could remain part of neuromuscular care, but more evidence is needed
- Human
Documented end-of-life decisions were linked to more comfort-focused care in a neurological ward
- Human
Rural residence was linked to more MAiD referrals in a Canadian ALS clinic study
- Human
U.S. registry study links multidisciplinary ALS clinic attendance with more specialized care
- Human
Hospital palliative care referrals for ALS often came late in the disease course
- Human
A two-center study identified factors linked to poorer survival after gastrostomy in ALS
A study reports longer hospital stays and more long-term complications after emergency tracheostomy in ALS
Community & Public Life
All Community & Public Life stories- Community & Stories Reporting
Finding meaning together in life after 16 years with ALS
- News & Culture Reporting
ALS Nexus 2026: Speaker shares hope navigating mom’s ALS
- Advocacy
The NIH NeuroBioBank (NBB) is a federated program supporting seven brain banks across the United States.
- News & Culture Reporting
'Pretty remarkable' man living with MND for 29 years after diagnosis
- News & Culture Reporting
Sterling K. Brown details mom's eight-year battle with ALS
- Advocacy ReportingMainly relevant to England.
Terminally ill campaigner’s urgent message to Andy Burnham
- News & Culture Reporting
Glasgow grandfather shares reality of MND ahead of major research event
- Advocacy
Meet Beth: Introducing our new Research Engagement and Involvement Manager
- News & Culture ReportingUpdated
Sandra Bullock speaks publicly about partner Bryan Randall’s private ALS battle
- AdvocacyMainly relevant to the United Kingdom.
Standing alongside families through every stage of MND
From Curalysis
- Clinical trials need to leave the clinic2 months ago
- There’s No Map for This5 months ago
- On the Inside of a Clinical Trial7 months ago
Summarised by Compass using AI from the source material. These are not medical advice. Always read the original source.